Robert Hamlin Jr

Robert Hamlin Jr. possesses extensive experience in clinical operations and study leadership within the pharmaceutical industry. Currently serving as Sr. Manager, Clinical Study Lead at Regeneron since October 2020, Robert previously held significant roles at The Janssen Pharmaceutical Companies of Johnson & Johnson as Functional Manager in Global Clinical Operations for Oncology and at Regeneron Pharmaceuticals as Manager, Clinical Study Lead. Robert's earlier career includes positions at Novartis Oncology and Amgen, where responsibilities included management of clinical operations and trials. Robert holds a Bachelor of Science degree in Molecular Biology from Kutztown University of Pennsylvania, earned in May 2004.